Connecting you to content on EBSCOhost

Works by Dennie, Justin

Results: 6

1

Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using <sup>18</sup>F-FDG PET/CT.

Published in:

Journal of Nuclear Medicine, 2015, v. 56, n. 10, p. 1520, doi. 10.2967/jnumed.115.159715

By:

Gheysens, Olivier;
Postnov, Andrey;
Deroose, Christophe M.;
Vandermeulen, Corinne;
de Hoon, Jan;
Declercq, Ruben;
Dennie, Justin;
Mixson, Lori;
De Lepeleire, Inge;
Van Laere, Koen;
Klimas, Michael;
Chakravarthy, Manu V.

Publication type:

Article

2

Asenapine pharmacokinetics and tolerability in a pediatric population.

Published in:

Drug Design, Development & Therapy, 2018, v. 12, p. 2677, doi. 10.2147/DDDT.S171475

By:

Dogterom, Peter;
Riesenberg, Robert;
Greef, Rik de;
Dennie, Justin;
Johnson, Martin;
Reddy, Venkatesh Pilla;
Miltenburg, André MM;
Findling, Robert L;
Jakate, Abhijeet;
Carrothers, Timothy J;
Troyer, Matthew D

Publication type:

Article

3

Lack of a clinically relevant effect of sugammadex on anti-Xa activity or activated partial thromboplastin time following pretreatment with either unfractionated or low-molecular-weight heparin in healthy subjects.

Published in:

International Journal of Clinical Pharmacology & Therapeutics, 2014, v. 52, n. 8, p. 631, doi. 10.5414/CP202091

By:

De Kam, Pieter-Jan;
Kruithof, Annelieke C.;
van Lierop, Marie-José;
Moerland, Matthijs;
Dennie, Justin;
Troyer, Matthew D.;
Langdon, Ronald B.;
Gutstein, David E.;
Burggraaf, Jacobus;
El Galta, Rachid

Publication type:

Article

4

Effect of Sugammadex on QT/QTc Interval Prolongation when Combined with QTc-Prolonging Sevoflurane or Propofol Anaesthesia.

Published in:

Clinical Drug Investigation, 2013, v. 33, n. 8, p. 545, doi. 10.1007/s40261-013-0095-8

By:

de Kam, Pieter-Jan;
Grobara, Peter;
Dennie, Justin;
Cammu, Guy;
Ramael, Steven;
Jagt-Smook, Marjan;
van den Heuvel, Michiel;
Berg, Rob;
Peeters, Pierre

Publication type:

Article

5

A Phase I, Single‐Ascending‐Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DS‐2969b, a Novel GyrB Inhibitor.

Published in:

Journal of Clinical Pharmacology, 2018, v. 58, n. 12, p. 1557, doi. 10.1002/jcph.1151

By:

Dennie, Justin;
Vandell, Alexander G.;
Inoue, Satoshi;
Gajee, Roohi;
Pav, Joseph;
Zhang, George;
Zamora, Cynthia;
Masuda, Nobuhisa;
Uchiyama, Minoru;
Yamada, Makiko;
Senaldi, Giorgio

Publication type:

Article

6

A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of DS-3801b, a Motilin Receptor Agonist, in Healthy Subjects.

Published in:

Journal of Clinical Pharmacology, 2017, v. 57, n. 9, p. 1221, doi. 10.1002/jcph.919

By:

Dennie, Justin;
Atiee, George;
Warren, Vance;
Tao, Ben;
Morimoto, Kiyoshi;
Senaldi, Giorgio

Publication type:

Article